Indolent B-cell Non-Hodgkin's Lymphoma
1 competing product in clinical development for Indolent B-cell Non-Hodgkin's Lymphoma.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| ME-401 | Kyowa Kirin | Phase 2 | Active | 39 |
1 competing product in clinical development for Indolent B-cell Non-Hodgkin's Lymphoma.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| ME-401 | Kyowa Kirin | Phase 2 | Active | 39 |